A few studies have been published on the possible moderating effect of APOE4 on the association between other vascular risks [such as hypertension (Yasuno et al., 2012), atherosclerosis (Haan et al., 1999), and peripheral vascular disease (Haan et al., 1999)] and cognitive decline. This evidence concerns the gene APOE and hypertensive disorder.